Startups
N-Power and its purpose-built clinical research platform empowers oncology practices and biopharma companies to accelerate drug development and make better-informed decisions. N-Power catalyzes clinical research by equipping oncology practices with the N-Power Platform and connecting them to industry research sponsors. The N-Power Platform consists of: - The real-time Kaleido™ Registry, conducted with patient consent, that defines standardized data collection at the point of care and is malleable to partner needs, - A technology solution that enables data collection and analysis, and - Embedded on-site and virtual staff who support delivery of routine care, implement standardized, registry protocol-defined data collection and augment site staff in clinical research. By partnering with oncologists, research staff and patients in unlocking the full potential of every patient’s data, we are expanding access to clinical trials and enabling unprecedented insights for biopharmaceutical drug development.
Overview
Total raised
$32M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 8
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 2, 2026 | N-Power Medicine Raises $32M in Series B Funding | N-Power Medicine, a Redwood City, CA-based provider of an oncology drug development and community cancer patient care platform, raised $32M in Series B funding. Backers included Labcorp Venture Fund, Merck Global Health Innovation Fund (Mer... |
| Sep 2, 2026 | SciFin Raises $44M in Seed Funding | SciFin, a San Jose, CA-based provider of an AI platform for enterprise revenue teams, raised $44M in Seed funding The round was co-led by Altimeter and Madrona with participation from Foundation Capital, S32, Zetta Ventures, and others. The... |
| Sep 1, 2026 | N-Power Medicine Closes $32M to Expand Community Oncology Research | What You Should Know Oncology drug development platform N-Power Medicine closed a $32M Series B financing round to scale its community oncology clinical research network and expand adoption of its Prospective External Control Arms (ProECA) ... |
| Jan 13, 2025 | N-Power Medicine Acquires Syapse | N-Power Medicine, a Redwood City, CA-based company improving clinical trial processes, acquired Syapse Holdings, a company which specializes in precision medicine solutions for community cancer centers. The amount of the deal was not disclo... |
| Jul 1, 2024 | N-Power Medicine raises Series B funding, partners with Merck | Merck's pipeline of clinical trials will be deployed in N-Power’s network sites Only 5% of cancer patients enroll in oncology clinical trials today because the majority of oncologists don’t participate in clinical research, especially in th... |
| Jul 1, 2024 | N-Power Medicine Raises Series B Funding | N-Power Medicine, a Redwood City, CA-based company which specializes in clinical trial processes, raised an undisclosed amount in Series B funding. The round, which brought the total amount to $72M, was led by Merck Global Health Innovation... |
| N-Power Medicine | “Accelerating drug development by reinventing the how - N-Power Medicine” |
Reviews 0
FAQ about N-Power Medicine
How much funding has N-Power Medicine raised?
N-Power Medicine has raised $32M in total across 1 funding round.
What has the press written about N-Power Medicine?
Parsers VC has collected 8 articles mentioning N-Power Medicine, among them “N-Power Medicine Raises $32M in Series B Funding” (Sep 2, 2026) and “SciFin Raises $44M in Seed Funding” (Sep 2, 2026).
Is N-Power Medicine still active?
Yes, N-Power Medicine is active; its latest activity on Parsers VC dates from Sep 2, 2026.